Tg Therapeutics (TGTX) Change in Acquisitions & Divestments (2015 - 2026)

Tg Therapeutics' Change in Acquisitions & Divestments history runs 12 years deep, the most recent figure standing at $11.2 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 86.01% year-over-year to $11.2 million; the TTM figure through Mar 2026 stood at $168.4 million (down 47.04% YoY), while the FY2025 annual figure was $237.5 million, down 23.61% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $11.2 million, down from $30.0 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $92.3 million in Q3 2024, with the low at $11.2 million in Q1 2026.
• The 5-year median for Change in Acquisitions & Divestments is $30.0 million (2025), against an average of $43.7 million.
• The sharpest annual moves came in 2024 and 2026: Change in Acquisitions & Divestments surged 358.76% in 2024, then sank 86.01% in 2026.
• Tg Therapeutics' Change in Acquisitions & Divestments stood at $20.3 million in 2022, then climbed by 16.81% to $23.7 million in 2023, then jumped by 211.26% to $73.7 million in 2024, then tumbled by 59.29% to $30.0 million in 2025, then slumped by 62.5% to $11.2 million in 2026.
• Business Quant data shows TGTX's Change in Acquisitions & Divestments at $11.2 million in Q1 2026, $30.0 million in Q4 2025, and $77.8 million in Q3 2025.